4536 — SANTEN PHARMACEUTICAL Share News
0.000.00%
- ¥558bn
- ¥537bn
- ¥292bn
Table: Santen Pharm -2022/23 group results (IFRS)
Table: Santen Pharm -2022/23 parent results
Table: Santen Pharm -2022/23 group forecast(IFRS)
Bought Back 1.2 Million Own Shares Worth 1.3 Billion Yen Between March 1 -March 24
Brief: Santen Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 3.3% Of Outstanding Stock On March 31
Announces Status Of Share Buyback In February
Table: Santen Pharm -9-MTH group results (IFRS)
Bought Back 3.6 Million Own Shares Worth 3.69 Billion Yen In January
Brief: Santen Pharmaceutical Co Ltd Announces Result Of Share Buyback For December
Brief: Santen Pharmaceutical Co Bought Back 2,275,800 Own Shares Worth 2.5 Billion Yen In December
Announces Result Of Share Buyback For Nov 9-30
Brief: Santen Pharmaceutical Co Ltd Says To Buy Back Up To 3.4% Of Own Shares Worth 13 Billion Yen
Table: Santen Pharm -6-MTH group results (IFRS)
Brief: Santen Pharmaceutical Co Ltd To Retire Treasury Shares Worth 3.1% Of Outstanding Stock On Oct 31
Brief: Santen Pharmaceutical - Bought Back 1,307,300 Own Shares From Sept 1 to 8
Bought Back 3,539,900 Own Shares In August
Table: Santen Pharm -Q1 group results (IFRS)
Bought Back 547,300 Own Shares Worth 596.4 Million Yen In July
Brief: Santen Pharmaceutical: To Buy Back Up To 3.1% Of Own Shares Worth 15 Billion Yen